Company / Accounts Receivable
Neogen Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$153.4M
FY2025
5-year range
$91.8M / $173.0M
FY2021-FY2025
Trend
-11.3%
vs FY2024
Sector context
#82 of 143
Health Care
What the data says
At $153M, Neogen's accounts receivable ranks #82 of 143 in the Health Care sector.
Based on SEC 10-K filings.
$153M in FY2025 with a 5-year CAGR of +12.6%.
Remained stable around $153M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +15.5%
- 5-Year CAGR
- +12.6%
- 10-Year CAGR
- -
Sector benchmark
#82 of 143 in Health CareTop 57% of 143This company $153.4M Sector average $1.3B
▼
-88.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.6%, indicating consistent growth.
- In FY2025, accounts receivable decreased 11.3% year-over-year.
- Ranks #82 out of 143 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $153.4M | -11.3% |
| FY2024 | $173.0M | +12.9% |
| FY2023 | $153.3M | +53.8% |
| FY2022 | $99.7M | +8.6% |
| FY2021 | $91.8M | +8.4% |
| FY2020 | $84.7M | +2.5% |
| FY2019 | $82.6M | +4.4% |
| FY2018 | $79.1M | +15.3% |
| FY2017 | $68.6M | +1.4% |
| FY2016 | $67.7M | +14.3% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026